Effect of penicillamine on serum iron.
Open Access
- 1 December 1965
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 40 (214), 651-653
- https://doi.org/10.1136/adc.40.214.651
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- HEPATO-LENTICULAR DEGENERATION (WILSON’S DISEASE) TREATED BY PENICILLAMINEBrain, 1964
- The Antipyridoxine Effect of Penicillamine in Man*JCI Insight, 1964
- Pyridoxine Deficiency in the Rat produced by D-PenicillamineNature, 1964
- Nephrotic syndrome associated with penicillamine therapy of Wilson's diseaseAmerican Journal Of Medicine, 1964
- CHELATING AGENTS IN WILSON'S DISEASEThe Lancet, 1963
- Treatment of Wilson's disease (hepatolenticular degeneration) with DL‐penicillamineNeurology, 1962
- TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINEThe Lancet, 1960
- The determination of the total iron-binding capacity of serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1957
- The determination of iron in blood plasma or serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1957
- An increased vitamin B6 requirement in the rat on a diet containing l-penicillamineArchives of Biochemistry and Biophysics, 1957